Navigation Links
DrugRisk Legal News Adds Latest Updates on NuvaRing Contraceptives
Date:1/11/2014

Kansas City, MO (PRWEB) January 11, 2014

The birth control safety center DrugRisk.com has updated its Legal News section for women using the contraceptive NuvaRing. Court records show Merck is challenging a generic version of the device, and the number of lawsuits alleging the device caused blood clot injuries has risen*.

DrugRisk is a free resource provided to those taking popular prescription drugs that shares the latest product recalls, safety alerts, research and litigation news. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

The site has added health warnings from experts such as the New England Journal of Medicine showing vaginal ring contraceptives like NuvaRing may result in a 6.5 times increased risk of blood clots**.

Now, DrugRisk has learned NuvaRing maker Merck has filed suit against Actavis over the company’s alleged marketing of a generic version of NuvaRing prior to the expiration of its patent in 2018***.

Due to the number of women who’ve filed a NuvaRing lawsuit alleging blood clots, cases have been consolidated in a special federal multidistrict litigation court. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

The latest court records show the number of cases filed has grown 3% in a month, from 1,563 on November 18th to 1,610 as of December 16*. U.S. District Judge Rodney Sippel has scheduled the first trial for April 7, 2014****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact DrugRisk or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judicial Panel on Multidistrict Litigation, 12/16/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-December-16-2013.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***Bloomberg, 12/24/13; bloomberg.com/news/2013-12-24/merck-sues-actavis-unit-over-patent-for-generic-nuvaring.html; Merck Sharp & Dohme BV v. Warner Chilcott Co., U.S. District Court, District of Delaware (Wilmington).
****U.S. District Judge Rodney Sippel, 10/8/13; aboutlawsuits.com/wp-content/uploads/2013-10-08-NuvaRing-Order.pdf

Read the full story at http://www.prweb.com/releases/2014-merck-nuvaring/settlement-lawsuits/prweb11482059.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New to DrugRisk: December Court Records Show Rise in NuvaRing Lawsuits
2. DrugRisk Adds Latest Court Update on DePuy Hip Lawsuits
3. DrugRisk Adds Latest Court Information For Januvia Lawsuits
4. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
5. DrugRisk Alerts of New Rise In Mirena Lawsuits Alleging Uterine Damage
6. DrugRisk Updates with Latest Case Numbers Since Januvia Lawsuits Sent to MDL Court
7. DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
8. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
9. DrugRisk Update: Latest Court Order Moves Mirena Lawsuits Forward
10. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
11. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
Breaking Medicine Technology: